Mid-Sized Medex Merges to Achieve Mass
Smiths Group, a diversified manufacturer operating in aerospace, industrial detection, specialty engineering, and medical products, is offering $925 million for Medex, a leader in medical safety devices and anesthesia. The deal is about merging complementary strengths in non-overlapping product areas to accelerate sales growth. And it's about critical mass: within a year, says Lawrence Kinet, board member of Smiths Medical, the newly merged medical division will join "the billion dollar club," an important threshold in the world of medical devices.
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.